Research found that over 90% of individuals with mild-to-moderate COVID-19 produce antibodies strong enough to neutralize SARS-CoV-2. The antibody response is relatively stable for at least five months, correlating with the body's ability to neutralize the virus.
Researchers found diverse cardiac structural damage in COVID-19 patients, including right ventricular dysfunction, regional left ventricular wall motion abnormalities, and diffuse left ventricular dysfunction. These abnormalities were associated with worse prognosis and mortality compared to troponin elevations alone.
Researchers propose a new theory that suggests the existence of a biodynamic interface between humans and their environment, which mediates interaction between biological and environmental systems. This interface considers social, behavioral, and cultural dynamics, allowing scientists to assess its impact on health outcomes.
A new study by Mount Sinai researchers found that a person's risk of uncontrolled chronic disease increases after moving to a place where the condition is more common. The study analyzed millions of adults who moved to new neighborhoods, counties, and states, tracing how their health changed after the move.
Researchers at Mount Sinai will lead capacity-building efforts for serological testing and analyze antibody responses in lung cancer patients. They will also examine the immune response to COVID-19 and its impact on vaccine development.
A new study reveals that microglia, immune cells in the brain, regulate behavioral responses by sensing neuronal activation and providing negative feedback. This novel mechanism of neuromodulation has implications for treating neurodegenerative and inflammatory diseases.
Researchers at Mount Sinai Hospital developed a COVID-19 mortality prediction model based on patient's age, minimum oxygen saturation, and type of encounter. The model showed high accuracy (AUC=0·91) in predicting mortality among patients with COVID-19, offering potential for improved prognostication and management.
Researchers identified thousands of rare epigenetic variations in the human genome, linked to abnormal gene expression and Mendelian diseases. The study highlights the significance of epivariations in contributing to a fraction of genetic diseases, including hereditary cancers.
Researchers found that heroin use alters the expression of the FYN gene, which regulates Tau production and is associated with neurodegenerative diseases like Alzheimer's. The study suggests that FYN inhibitors may be a promising therapeutic tool for opioid addiction.
Researchers found higher TMPRSS2 expression in Blacks compared to Asians, Latinos, and Whites, which may contribute to COVID-19 risk disparities. The study emphasizes the importance of diverse participants in clinical trials and addressing social determinants of health.
Researchers identified a specific brain circuit vulnerable to juvenile social isolation in mice, which may lead to treatments for sociability deficits and psychiatric disorders. Stimulation of this circuit restored normal social behavior in adult mice with juvenile isolation.
Researchers found that therapeutic and prophylactic doses of blood thinners reduced mortality by roughly 50 percent in COVID-19 patients. The study also showed that anticoagulation therapy was associated with improved outcomes both in and out of the intensive care unit.
Scientists at The Mount Sinai Hospital have discovered two inflammation markers that reliably predict COVID-19 severity and survival. Elevated levels of IL-6 and TNF-α in serum indicate a higher risk of death, allowing for early stratification and treatment optimization.
A Mount Sinai study found that COVID patients were most commonly readmitted to the hospital for respiratory distress, with chronic obstructive pulmonary disease and hypertension being key comorbidities. The study also showed that these patients had shorter hospital stays and lower rates of anticoagulation treatment.
A recent study published in JAMA Network Open found that trauma-exposed adolescents with moderately elevated acyl-ghrelin hormone levels are almost eight times more likely to develop post-traumatic stress disorder (PTSD). The study also suggests that lower acyl-ghrelin levels may reduce the risk and severity of subsequent PTSD.
Researchers have identified master regulator genes that causally regulate key biological processes underlying asthma. These genes provide a novel path forward for uncovering mechanisms and developing novel therapies for asthma. The study also identified nasal gene signatures for mild, moderate, and severe persistent asthma.
A new study suggests that COVID-19 is causing significant dilation of the lung's blood vessels, contributing to low oxygen levels and unusual respiratory behavior. The dilation was detected using a non-invasive ultrasound technique, and its correlation with oxygen levels may help explain why some patients experience 'happy hypoxia.'
A new study has identified a better treatment option for arteriovenous fistulas used in hemodialysis, reducing the need for repeated hospital visits and procedures. The drug-coated balloon angioplasty treatment has shown promising results, with patients being 25% more likely to have a functioning access point after 6 months.
Researchers have designed a new X-ray classification system for adult idiopathic scoliosis, providing a more universal and standard assessment of the condition. The three-component method maintains existing curve types while introducing assessments of global alignment and lumbosacral curve, improving treatment options for older patients.
Scientists have unraveled the structure and mechanism of DNA polymerase ζ, an enzyme that replicates through daily DNA-damaging events. This discovery offers valuable insights into developing effective inhibitors to make cancer cells more sensitive to chemotherapy.
A study found that two blood epigenetic signatures associated with ADNP syndrome have only modest correlation with clinical manifestations. Researchers conclude that these signatures should be carefully evaluated before being considered as biomarkers for predicting behavioral outcomes.
Researchers at Mount Sinai Hospital have discovered a novel genetic sequencing technology that identified the cause and treatment of a previously unknown severe auto-inflammatory syndrome. The technology, tailored to the patient's own genetic code, pinpointed an unknown mutation in the JAK1 gene causing permanent immune system activation.
Researchers pinpointed a single gene biomarker, nitride oxide synthase 2 (NOS2), to distinguish between atopic dermatitis and psoriasis with 100% accuracy using adhesive tape strips. The study identifies distinct immune response markers for each disease.
Researchers found that roflumilast cream significantly improved psoriasis signs and symptoms in as early as two weeks, with clear skin, itch reduction, and burden of disease improvement. The treatment showed promise for patients with plaque psoriasis lacking suitable options.
Researchers discovered a novel potassium channel activator, GiGA1, that selectively opens GIRK channels and reduces neuronal excitability. Systemic administration of GiGA1 exhibits anti-seizure properties in an acute epilepsy animal model.
A study published in the American Journal of Neuroradiology found COVID-19 infection to be significantly associated with acute ischemic stroke. After adjusting for age, gender, and risk factors, the researchers showed a 3.9-fold increased risk of stroke among patients with COVID-19 compared to control subjects.
Researchers identified reproductive and metabolic subtypes of PCOS associated with novel gene regions, promising to transform understanding of the disorder. The study used clustering of clinical, metabolic, and hormonal data from women with PCOS, revealing two distinct subtypes with different genetic architectures.
A study published in Cell reveals that viruses can produce previously undetected proteins by stitching together host and viral sequences, altering the course of viral infection. These new proteins could be exploited for vaccine purposes and may hold key to understanding viral virulence.
A study found that 36% of hospitalized COVID-19 patients had heart damage, leading to a three times higher risk of death. Patients with mild myocardial injury still faced a 75% higher risk of death compared to those with normal levels.
A study published in Cell Reports reveals that human acute myeloid leukemia (AML) stem cells are dependent on the transcription factor RUNX1, which could lead to lasting remissions or even cures. The researchers used induced pluripotent stem cells from a patient with AML to recreate leukemia stem cell biology in the lab.
A Mount Sinai research team has identified the scaffolding protein histone deacetylase 3 (HDAC3) as essential for proper skin development and barrier formation. Mice lacking HDAC3 in the epidermis fail to develop a functional skin barrier, leading to dehydration and death shortly after birth.
Mount Sinai researchers found lower ACE2 expression in younger children, increasing with age. This could help explain why children are less likely to get COVID-19 and account for only 2% of identified cases.
Scientists discovered biological markers in teeth of children who later developed ALS, shedding light on the disease's early stages and potential preventive strategies. The study found abnormal metal uptake patterns, suggesting a link between environmental factors and disease onset.
Researchers developed an AI model using CT scans and clinical data to diagnose COVID-19, achieving higher sensitivity than radiologists. The algorithm can rapidly detect the virus, isolate patients, and prevent its spread during pandemics.
Researchers used chest X-rays to identify patients at higher risk of severe illness from COVID-19. A unique scoring system evaluated lung patterns, predicting outcomes and guiding treatment for high-risk patients.
A clinical trial led by Mount Sinai researchers showed that combining chemotherapy and immunotherapy can significantly delay the progression of metastatic bladder cancer. The trial also found that immunotherapy alone may be an option for patients with high PD-L1 protein expression in their tumors.
A new study by Mount Sinai researchers found that insulin resistance is a key factor mediating racial disparities in breast cancer prognosis. Black women with invasive breast cancer had higher rates of insulin resistance and more aggressive tumors than white women.
Researchers found that anticoagulants improved survival rates among COVID-19 patients in and out of the intensive care unit setting. Treatment with anticoagulants was associated with reduced mortality and longer hospital stays for ventilated patients.
A study analyzing NYC birth data found stark differences in severe maternal morbidity risk across neighborhoods with extreme racial and economic polarization. Black and Latina women faced the largest magnitude of associations with severe maternal morbidity.
Researchers at Mount Sinai have identified a novel class of genes, specifically LINC00473, that regulate mood and drive sex-specific susceptibility versus resilience to depression. These findings provide evidence for an important new family of molecular targets that could help scientists develop more effective pharmacotherapies.
A clinical trial found that immunotherapy significantly slowed the worsening of urothelial cancer when given after platinum-based chemotherapy, with a 60% longer time to cancer progression compared to the control group. The switch maintenance immunotherapy approach is expected to become a standard of care for metastatic bladder cancer.
Dopamine plays a critical role in regulating gene expression, particularly in the context of cocaine abuse. Histone dopaminylation affects brain regions involved in motivation and reward behavior.
A new study found that nicotinamide inhibits aggressive cell transformations and reverses the development of fibrous membranes in the retina, potentially treating fibrotic eye diseases. The compound also promotes the transition from mesenchymal to epithelial cells, helping to preserve their original identity.
Researchers at Mount Sinai have found a way to regulate special immune system cells in lung cancer tumors, suppressing them and allowing tumors to grow. By blocking this pathway, the immune system can be boosted to prevent tumor formation or growth, offering a potential new treatment for immunotherapy.
Researchers identified predictive models for Crohn's disease, including a serum biomarker model with 76% accuracy, and explored the link between metal exposure in early life and IBD risk. Achieving deep remission early on was also associated with a significant decrease in long-term complications.
A new study identifies Plexin-B2 as a key protein in wound healing and neural repair following spinal cord injury. The finding could aid the development of therapies targeting axon guidance pathways for more effective treatment of SCI patients.
Researchers at Mount Sinai have discovered a method to increase the potency of hematopoietic stem cells, which could improve bone marrow transplants. By manipulating lysosomal activity, they enhanced the potency of these stem cells by over 90-fold.
Researchers at Mount Sinai have developed an AI model that can accurately determine the type of lower back pain by analyzing clinical notes in electronic medical records. This breakthrough could lead to improved treatment options, reduced opioid prescriptions, and more accurate billing and therapy recommendations.
Mount Sinai physicians analyzed chest CT scans of Chinese COVID-19 patients, identifying specific patterns in lung disease as it develops over a week and a half. The study could lead to quicker diagnosis and prompt isolation in early stages.
A new brain scan-blood test panel has been developed to help diagnose brain trauma following battlefield blasts. The panel combines functional assessment with blood tests and brain scans to estimate brain degeneration in human veterans exposed to IED blasts.